Yayın: A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects
| dc.contributor.author | BAYSAL, MERVE | |
| dc.contributor.author | Atlı, Özlem | |
| dc.contributor.author | Vishnu Nayak Badavath | |
| dc.contributor.author | Antonio Laghezza | |
| dc.contributor.author | Fabrizio Dal Piaz | |
| dc.contributor.author | Susanta Mondal | |
| dc.contributor.author | Özlem Atlı | |
| dc.contributor.author | Merve Baysal | |
| dc.contributor.author | Vadivelan Sankaran | |
| dc.contributor.author | Saranya Shankar | |
| dc.contributor.author | Mohd Usman Mohd Siddique | |
| dc.contributor.author | Ashok Pattnaik | |
| dc.contributor.author | Ravi Pratap Singh | |
| dc.contributor.author | Fulvio Loiodice | |
| dc.contributor.author | Venkatesan Jayaprakash | |
| dc.contributor.author | Antonio Lavecchia | |
| dc.contributor.orcid | 0000-0001-8399-1230 | |
| dc.contributor.orcid | 0000-0002-6631-5000 | |
| dc.contributor.orcid | 0000-0002-6433-2691 | |
| dc.contributor.orcid | 0000-0001-6221-6155 | |
| dc.contributor.orcid | 0000-0002-8643-5018 | |
| dc.contributor.orcid | 0009-0005-9505-0565 | |
| dc.contributor.orcid | 0000-0002-8099-0942 | |
| dc.contributor.orcid | 0000-0002-3050-8708 | |
| dc.contributor.orcid | 0000-0001-9503-1771 | |
| dc.contributor.orcid | 0000-0003-2931-9042 | |
| dc.contributor.orcid | 0000-0002-2077-9619 | |
| dc.contributor.orcid | 0000-0003-3384-574X | |
| dc.contributor.orcid | 0000-0002-9724-4153 | |
| dc.contributor.orcid | 0000-0002-2181-8026 | |
| dc.date.accessioned | 2025-11-13T10:15:06Z | |
| dc.date.issued | 2020-10-08 | |
| dc.identifier.doi | https://doi.org/10.1002/cmdc.202000564 | |
| dc.identifier.endpage | 498 | |
| dc.identifier.issn | 1860-7179 | |
| dc.identifier.issue | 3 | |
| dc.identifier.openalex | W3092474088 | |
| dc.identifier.startpage | 484 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3584 | |
| dc.identifier.uri | https://doi.org/10.1002/cmdc.202000564 | |
| dc.identifier.volume | 16 | |
| dc.language.iso | en | |
| dc.relation.ispartof | ChemMedChem | |
| dc.rights | openAccess | |
| dc.subject | Ferulic acid | |
| dc.subject | Insulin resistance | |
| dc.subject | Chemistry | |
| dc.subject | In vivo | |
| dc.subject | Pharmacology | |
| dc.subject | Antioxidant | |
| dc.subject | Hyperlipidemia | |
| dc.subject | Biochemistry | |
| dc.subject | Insulin | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Endocrinology | |
| dc.subject | Biology | |
| dc.subject.sdg | 3 | |
| dc.title | A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5027386527 | |
| local.authorid.openalex | A5110553744 |
